Trevena Inc (TRVN)

[lattices]

The market will tell us how wrong or right we are -- I just don't understand what other people see. They're probably smarter than me. There wasn't any price that was low enough today -- the market seemed to indicate there's no reason shares won't continue to go lower.

The report today had information which triggered a stampede -- what was it? To my uninformed view, everything was what I expected. Possibly the amount of cash in Q4 was materially higher?

My stab-in-the-dark guess is that today's report sucked remaining hope from those who owned the stock at $7, before data, that the drug would be a big seller, or that sales would take off quickly. To my ear, the company had a clearer focus on those situations where it might gain adoption. Would the analysts see any market size change from what they saw two weeks ago, post-data? I doubt it.

I never experienced the sickening collapse post data, where the market opened at $5, 40% lower than the pre data close, and anyone holding had to watch shares fall well over an additional 20%+ from there.

....Another day tomorrow...meanwhile I wish someone could explain what I'm missing here. From what I can tell, this remains a quick revenue expansion product from it's mid-2018 launch, with international licensing tipping almost to likely. Did the market learn something today that reduced the net-of-cash value of the company by 20%? I didn't see it/